Association between platelet glycoprotein Ibα genotype and ischemic cerebrovascular disease

Stroke

Volumn 31, Issue 2, 2000, Pages 493-497

  Sonoda, Akira ^a   Murata, Mitsuru ^a   Ito, Daisuke ^a   Tanahashi, Norio ^a   Ohta, Atsumi ^a   Tada, Yoko ^a   Takeshita, Eiko ^a   Yoshida, Tadashi ^a   Saito, Ikuo ^a   Yamamoto, Masatoshi ^b   Ikeda, Yasuo ^a   Fukuuchi, Yasuo ^a   Watanabe, Kiyoaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b Sankyo Inc   (Japan)

Author keywords

Cerebrovascular disorders; Genetics; Platelets; Polymorphism; Thrombosis

Indexed keywords

THROMBIN RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATION FUNCTION; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE ACTIVATION;

EID: 0033980198     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.2.493     Document Type: Article

References (35)

1. Fustcr V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;356:242-250.
2. del Zoppo GJ. The role of platelets in ischemic stroke. Neurology. 1998;51(3 suppl 3):S9-14.
3. Harker LA. Therapeutic inhibition of platelet function in stroke. Cerebrovasc Dis. 1998;8(suppl 5):8-18.
4. Peterson DM, Stathopoulos NA, Giorgio TD, Hellumus JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet glycoproteins Ib and IIb-IIIa. Blood. 1987;69:625-628.
5. Ikeda Y, Handa M, Kawano K, Kamaia T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991;87:1234-1240.
6. Chow TW, Hellums JD, Moake KL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992;80:113-120.
7. Kroll MH, Hellums JD, Guo Z, Durante W, Razdan K, Hrbolich JK, Schafer AI. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem. 1993;268:3520-3524.
8. Weiss HJ. Flow-related platelet deposition on subendothelium. Thromb Haemost. 1995;74:117-122.
9. Kroll MH, Heliums JD, McIntire LV, Schafer AI, Moak JL. Platelets and shear stress. Blood. 1996;88:1525-1541.
10. Ikeda Y, Murata M, Goto S. von Willebrand factor-dependent shear-induced platelet aggregation: basic mechanisms and clinical implications. Ann N Y Acad Sci. 1997;811:323-336.
11. Tokuue J, Hayashi J, Hata Y, Nakahara K, Ikeda Y. Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina. Thromb Haemost. 1996;75:833-837.
12. Uchiyama S, Yamazaki M, Maruyama S, Handa M, Ikeda Y, Fukuyama M, Itagaki I. Shear-induced platelet aggregation in cerebral ischemia. Stroke. 1994;25:1547-1551.
13. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis. 1994;5:97-119.
14. Clemetson KJ. Platelet GPIb-V-IX complex. Thromb Haemost. 1997;78: 266-270.
15. Wenger RH, Kieffer AN, Wicki N, Clemetson KJ. Structure of the human platelet membrane glycoprotein Iba gene. Biochem Biophys Res Commun. 1998;156:389-395.
16. Kuijipers RWAM, Faber NM, Cuypers HThM, Ouwehand WH, von dem Borne AEGKr. NH2-terminal globular domain of human platelet glycoprotein Iba has a methionine 145/threonine 145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest. 1992;89:381-384.
17. Murata M, Furihata K, Ishida F, Russell SR, Ware J, Ruggen ZM. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Iba involved in platelet transfusion refractoriness. Blood. 1992;79:3086-3090.
18. Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region: structure/function implications. J Biol Chem. 1992;267:10055-10056.
19. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, Lopez JA. Kozak sequence polymorphism of the glycoprotein (GP) Ib alpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood. 1999;94:186-191.
20. Murata M, Matsubara Y, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation. 1997;96:3281-3286.
21. Gonzalez-Conejero R. Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood. 1998;92: 2771-2776.
22. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa). von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke. 1997;28:1392-1395.
23. Carter AM, Catto AJ, Bamford JM, Grant PJ. Platelet GPIIIa P1A1 and GPIb variable number of tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol. 1998; 18:1124-1131.
24. Ad Hoc Committee of National Institute of Neurological Disorders and Stroke. Classification of Cerebrovascular Diseases III. Stroke. 1990;21: 637-676.
25. Sankai T, Miyagaki T, Iso H, Shimamoto T, Iida M, Tanigaki M, Naito Y, Sato S, Kiyama M, Kitamura A. A population-based study of the proportion by type of stroke determined by computed tomography scan. Nippon Koshu Eisei Zasshi. 1991;38:901-909.
26. AIberti KGMM, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications-Part 1: diagnosis and classification of diabetes mellitus-provisional report of a WHO consultation. Diabet Med. 1998;15:539.
27. Bray P. Integrin polymorphisms as risk factors for thrombosis. Thromb Haemost. 1999;82:337-344.
28. Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Goldschmidt-Clermont PJ, Croft JB, Brown VK, Stem BJ, Feeser BR, Buchholz DW, Earley CJ, Macko RF, McCarter RJ, Sloan MA, Stolley PD, Wityk RJ, Wozniak MA, Price TR, Kittner SJ. Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke. 1998;29:581-585.
29. Nichols TC, Bellinger DA, Reddick RL, Read MS, Koch GG, Brinkhous KM Griggs TR. Role of von Willebrand factor in arterial thrombosis. Circulation. 1991;83(suppl IV):IV-56-IV-64.
30. Strony J, Phillips M, Brands D, Moake J, Adelman B. Aurintricarboxylic acid in a canine model of coronary artery thrombosis. Circulation. 1990; 81:1106-1114.
31. Yao SK, Ober JC, Garfinkel LI, Hagay Y, Ezov N, Ferguson JJ, Andrson HV, Panet A, Gorecki M, Buja LM, Willerson JT. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation. 1994;89:2822-2828.
32. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:351-355.
33. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
34. Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A. The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood. 1999;93:3583-3586.
35. Legier TJ, Kohler M, Mayr WR, Panzer S, Ohio H, Fischer GF. Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing. Transfusion. 1996; 36:426-431.